Effectiveness of zopiclone in disorders of initiating and maintaining sleep.
Results of a drug monitoring study in 811 general practices
by
Wiegand MH, Roszinsky-Kocher G, Schwalb B, Fischer W, Eckert MW.
Klinik und Poliklinik fur Psychiatrie
und Psychotherapie der Technischen Universitat Munchen.
Fortschr Med Orig 2001;119(1):25-32

ABSTRACT

BACKGROUND AND METHOD: In a drug monitoring study with 811 participating general practitioners, safety and tolerability of zopiclone were studied in 2416 patients with disorders of initiating and maintaining sleep. RESULTS: In general, zopiclone was efficient in all forms of insomnia; the subjective sleep duration was prolonged for 2 hours on average. Patients without somatic complaints or comorbidity showed the greatest benefit. Daytime well-being and vigilance were in general not impaired. Drug related adverse events occurred rarely; the great majority of the participating physicians rated the treatment with zopiclone as efficient and acceptable. CONCLUSION: In this drug monitoring study, zopiclone proved an efficient hypnotic for the treatment of disorders of initiating and maintaining sleep.

Insomnia
Sedatives
Alprazolam
Benzodiazepines
Zopiclone drivers
Sleeping-pill hype?
Zopiclone: structure
Zopiclone v zolpidem
Eszopiclone (Lunesta)
Zopiclone: pharmacokinetics
Zopiclone (Imovane) : structure
Zopiclone and desmethylzopiclone
Nightly eszopiclone (Lunesta) for insomniacs
Eszopiclone (Lunesta): prescribing information (PDF)
The new sleeping pills: Lunesta, Sonata and Rozerem

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family